Skip to main content
. 2021 Jan 21;76(7):1184–1191. doi: 10.1093/gerona/glab019

Table 1.

Patient Characteristics

Whey Protein EAA Education Only
Category Specific Factor n n n
NYHA class NYHA class 1 13 11 6
NYHA class 2 17 14 21
NYHA class 3 2 3 3
NYHA class 4 0 0 0
Echocardiography EF ≥ 60% 15 14 11
EF ≤ 40%–55% 2 1 1
Other comorbidities HTN 26 18 19
HLP 12 12 7
Atrial fibrillation 4 3 0
Pacemaker and/or defibrillator 1 1 0
CAD 8 9 4
DM 3 1 5
COPD/other lung disease 4 6 3
Medications ACEI/ARB 19 12 11
Beta-blockers 11 11 5
Calcium channel blockers 14 10 9
Diuretics 13 7 10
Anti-arrhythmias 2 2 0
Short- or long-acting nitrates 1 1 2
Statins 17 10 3

Note: ACEI = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; DM = diabetes mellitus; EAA = essential amino acid; EF = ejection fraction; HLP = hyperlipidemia; HTN = hypertension; NYHA = New York Heart Association.